Researchers from the RIKEN Center for Integrative Medical Sciences in Japan found that the by-product butyrate acts as an epigenetic switch that boosts the immune system by inducing the production of regulatory T cells in the gut.
Previous studies have shown that patients suffering from inflammatory bowel disease lack butyrate-producing bacteria and have lower levels of butyrate in their gut.
However, butyrate's anti-inflammatory properties were attributed to its role as main energy source for the cells lining the colon.
This study is the first to provide a molecular basis for the role of butyrate on the production of regulatory T lymphocytes.
More From This Section
Their research demonstrates that butyric acid, a short-chain fatty acid produced by commensal bacteria acts on naive T cells to promote their differentiation into Treg cells.
It achieves this through epigenetic changes that regulate the expression of the genes responsible for differentiation of naive T cells into Treg cells.
The study shows that mice suffering from colitis see their levels of Treg cells increase and their symptoms improve after administration of butyrate as part of their diet.
The study is published in the journal Nature.